It is now known that HLA-DR, particularly the HLA-DRB1*04 variant, plays a crucial role in RA pathogenesis by presenting extracellular antigens (e.g., bacterial or viral protein fragments) to helper T (CD4+) cells. This evidence concerns the gene CD4 and rheumatoid arthritis.